Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation - PubMed (original) (raw)
Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation
Hans-Joachim Lüth et al. Brain Res. 2002.
Abstract
Various isoforms of the nitric oxide (NO) producing enzyme nitric oxide synthase (NOS) are elevated in Alzheimer's disease (AD) indicating a critical role for NO in the pathomechanism. NO can react with superoxide to generate peroxynitrite, a process referred to as oxidative stress, which is likely to play a role in AD. Peroxynitrite in turn, nitrates tyrosine residues to form nitrotyrosine which can be identified immunohistochemically. To study the potential structural link between the increased synthesis of NO and the deposition of nitrotyrosine in AD, we analyzed the expression of neuronal NOS (nNOS), inducible NOS (iNOS) and endothelial NOS (eNOS) in AD and control brain, and compared the localization with the distribution of nitrotyrosine. Nitrotyrosine was detected in neurons, astrocytes and blood vessels in AD cases. Aberrant expression of nNOS in cortical pyramidal cells was highly co-localized with nitrotyrosine. Furthermore, iNOS and eNOS were highly expressed in astrocytes in AD. In addition, double immunolabeling studies revealed that in these glial cells iNOS and eNOS are co-localized with nitrotyrosine. Therefore, it is suggested that increased expression of all NOS isoforms in astrocytes and neurons contributes to the synthesis of peroxynitrite which leads to generation of nitrotyrosine. In view of the wide range of isoform-specific NOS inhibitors, the determination of the most responsible isoform of NOS for the formation of peroxynitrite in AD could be of therapeutic importance in the treatment of Alzheimer's disease.
Similar articles
- Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a.
Lüth HJ, Holzer M, Gertz HJ, Arendt T. Lüth HJ, et al. Brain Res. 2000 Jan 3;852(1):45-55. doi: 10.1016/s0006-8993(99)02178-2. Brain Res. 2000. PMID: 10661494 - Expression of nitric oxide system in clinically evaluated cases of Alzheimer's disease.
Fernández-Vizarra P, Fernández AP, Castro-Blanco S, Encinas JM, Serrano J, Bentura ML, Muñoz P, Martínez-Murillo R, Rodrigo J. Fernández-Vizarra P, et al. Neurobiol Dis. 2004 Mar;15(2):287-305. doi: 10.1016/j.nbd.2003.10.010. Neurobiol Dis. 2004. PMID: 15006699 - Role of aberrant nitric oxide synthase-3 expression in cerebrovascular degeneration and vascular-mediated injury in Alzheimer's disease.
de la Monte SM, Sohn YK, Etienne D, Kraft J, Wands JR. de la Monte SM, et al. Ann N Y Acad Sci. 2000 Apr;903:61-71. doi: 10.1111/j.1749-6632.2000.tb06351.x. Ann N Y Acad Sci. 2000. PMID: 10818490 Review. - Alzheimer's Disease: A Contextual Link with Nitric Oxide Synthase.
Dubey H, Gulati K, Ray A. Dubey H, et al. Curr Mol Med. 2020;20(7):505-515. doi: 10.2174/1566524019666191129103117. Curr Mol Med. 2020. PMID: 31782366 Review.
Cited by
- Oxidative Stress in Neurodegenerative Diseases.
Niedzielska E, Smaga I, Gawlik M, Moniczewski A, Stankowicz P, Pera J, Filip M. Niedzielska E, et al. Mol Neurobiol. 2016 Aug;53(6):4094-4125. doi: 10.1007/s12035-015-9337-5. Epub 2015 Jul 22. Mol Neurobiol. 2016. PMID: 26198567 Free PMC article. Review. - APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).
Lalonde R, Fukuchi K, Strazielle C. Lalonde R, et al. Neurosci Biobehav Rev. 2012 May;36(5):1357-75. doi: 10.1016/j.neubiorev.2012.02.011. Epub 2012 Feb 21. Neurosci Biobehav Rev. 2012. PMID: 22373961 Free PMC article. Review. - Association of neuronal nitric oxide synthase C276T polymorphism with Alzheimer's disease.
Galimberti D, Venturelli E, Gatti A, Lovati C, Fenoglio C, Mariani C, Forloni G, Bresolin N, Scarpini E. Galimberti D, et al. J Neurol. 2005 Aug;252(8):985-6. doi: 10.1007/s00415-005-0783-2. Epub 2005 Mar 17. J Neurol. 2005. PMID: 15765269 No abstract available. - Bacopa monnieri prevents colchicine-induced dementia by anti-inflammatory action.
Saini N, Singh D, Sandhir R. Saini N, et al. Metab Brain Dis. 2019 Apr;34(2):505-518. doi: 10.1007/s11011-018-0332-1. Epub 2019 Jan 2. Metab Brain Dis. 2019. PMID: 30604025 - Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase.
Nathan C, Calingasan N, Nezezon J, Ding A, Lucia MS, La Perle K, Fuortes M, Lin M, Ehrt S, Kwon NS, Chen J, Vodovotz Y, Kipiani K, Beal MF. Nathan C, et al. J Exp Med. 2005 Nov 7;202(9):1163-9. doi: 10.1084/jem.20051529. Epub 2005 Oct 31. J Exp Med. 2005. PMID: 16260491 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical